Two Sigma Securities, LLC Abb Vie Inc. Call Options Transaction History

Two Sigma Securities, LLC

$8.19 Billion
Q2 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $20.8 Million - $24.2 Million	-134,100 Reduced 50.06%	133,800 $22.9 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $13.8 Million - $15.8 Million	86,600 Added 47.77%	267,900 $48.8 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $11.7 Million - $13.2 Million	-85,200 Reduced 31.97%	181,300 $28.1 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $11.3 Million - $13 Million	84,300 Added 46.27%	266,500 $39.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $2.41 Million - $3 Million	-18,200 Reduced 9.08%	182,200 $24.5 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $4.53 Million - $5.21 Million	31,300 Added 18.51%	200,400 $31.9 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $788,367 - $945,459	5,700 Added 3.49%	169,100 $27.3 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.55 Million - $2.92 Million	-19,000 Reduced 10.42%	163,400 $21.9 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $17.5 Million - $22.3 Million	127,200 Added 230.43%	182,400 $27.9 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $2.82 Million - $3.5 Million	21,400 Added 63.31%	55,200 $8.95 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $180,880 - $205,326	-1,700 Reduced 4.79%	33,800 $3.65 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $3.3 Million - $3.68 Million	31,400 Added 765.85%	35,500 $4 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $2.71 Million - $2.98 Million	-26,500 Reduced 86.6%	4,100 $444,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $1.44 Million - $1.95 Million	17,900 Added 140.94%	30,600 $3.28 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $2.96 Million - $3.47 Million	-34,400 Reduced 73.04%	12,700 $1.11 Million
Q2 2020 Sep 10, 2020	SELL	$73.37 - $98.18 $4.45 Million - $5.96 Million	-60,700 Reduced 56.31%	47,100 $4.62 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $8.22 Million - $12.5 Million	-127,500 Reduced 54.19%	107,800 $8.21 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $10.1 Million - $12.6 Million	-140,000 Reduced 37.3%	235,300 $20.8 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $16.5 Million - $21.1 Million	251,800 Added 203.89%	375,300 $27.3 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $17.3 Million - $20.4 Million	-224,700 Reduced 64.53%	123,500 $9.95 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $295,830 - $364,838	3,800 Added 1.1%	348,200 $32.1 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $6.15 Million - $6.84 Million	-69,200 Reduced 16.73%	344,400 $32.6 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $19.3 Million - $22.9 Million	-215,100 Reduced 34.21%	413,600 $38.3 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $55.9 Million - $74.8 Million	607,200 Added 2824.19%	628,700 $59.5 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $1.93 Million - $2.11 Million	21,500	21,500 $2.08 Million

Others Institutions Holding ABBV

# of Institutions

3,771

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$34.7 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$27.8 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.8 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

53.6M
Shares

$10.9 Billion
0.81% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.86 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account